Marshall Wace North America’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $2.32M | Sell |
32,866
-44,423
| -57% | -$3.14M | 0.01% | 682 |
|
|
2021
Q2 | $5.15M | Buy |
+77,289
| New | +$5.15M | 0.02% | 535 |
|
|
2020
Q1 | – | Sell |
-20,671
| Closed | -$2.38M | – | 1382 |
|
|
2019
Q4 | $2.38M | Buy |
+20,671
| New | +$2.38M | 0.01% | 539 |
|
|
2019
Q3 | – | Sell |
-34,646
| Closed | -$4.17M | – | 1393 |
|
|
2019
Q2 | $4.17M | Buy |
34,646
+27,787
| +405% | +$3.34M | 0.03% | 403 |
|
|
2019
Q1 | $600K | Buy |
6,859
+4,419
| +181% | +$387K | ﹤0.01% | 760 |
|
|
2018
Q4 | $244K | Buy |
+2,440
| New | +$244K | ﹤0.01% | 922 |
|
|
2018
Q3 | – | Sell |
-172,918
| Closed | -$15.5M | – | 1090 |
|
|
2018
Q2 | $15.5M | Buy |
172,918
+48,270
| +39% | +$4.33M | 0.09% | 249 |
|
|
2018
Q1 | $9.12M | Sell |
124,648
-155,163
| -55% | -$11.4M | 0.05% | 419 |
|
|
2017
Q4 | $16.3M | Buy |
279,811
+197,942
| +242% | +$11.5M | 0.09% | 269 |
|
|
2017
Q3 | $3.68M | Buy |
+81,869
| New | +$3.68M | 0.02% | 632 |
|
|
2013
Q3 | – | Sell |
-12,663
| Closed | -$524K | – | 650 |
|
|
2013
Q2 | $524K | Buy |
+12,663
| New | +$524K | 0.04% | 307 |
|